Cross-sectional survey of the prevalence of reduced estimated glomerular filtration rate, albuminuria and cardiovascular risk in a native Spanish population

Journal of Nephrology

Volumn 26, Issue 4, 2013, Pages 675-682

  Robles, Nicolas R ^a   Felix, Francisco J ^b   Fernandez Berges, Daniel ^c,d,e   Perez Castán, Jose F ^d   Zaro, Maria J ^e   Lozano, Luis ^f   Alvarez Palacios, Paula ^c   Garcia Trigo, Antonio ^c   Tejero, Veronica ^c   Morcillo, Yolanda ^c   Hidalgo, Ana B ^c  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b Centro de Salud Villanueva de la Serena   (Spain)

^c Programa de Investigación en Enfermedades Cardiovasculares   (Spain)

^d Area Health Service   (Spain)

^e Villanueva de la Serena   (Spain)

^f Health Center Merida   (Spain)

Author keywords

Chronic kidney disease; CKD EPI formula; MDRD formula

Indexed keywords

ADULT; AGED; ALBUMINURIA; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; DYSLIPIDEMIA; FEMALE; GLOMERULUS FILTRATION RATE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; OBESITY; OBSERVATIONAL STUDY; POPULATION RESEARCH; PREVALENCE; RISK ASSESSMENT; SEX DIFFERENCE; SPAIN; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; AGED, 80 AND OVER; ALBUMINURIA; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SPAIN;

EID: 84880113839     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.5301/jn.5000221     Document Type: Article

References (30)

1. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41(1):1-12.
2. US Renal Data Systems. USRDS 2006 annual data report: atlas of end stage renal diseases in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease, Division of Kidney, Urologic, and Hematologic Diseases; 2006.
3. Levey AS, Beto JA, Coronado BE, et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis. 1998;32(5):853-906.
4. Locatelli F, Vecchio LD, Pozzoni P. The importance of early detection of chronic kidney disease. Nephrol Dial Transplant. 2002;17(Suppl 11):2-7.
5. Zhang QL, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health. 2008;8(1):117-130.
6. Otero A, de Francisco A, Gayoso P, García F; EPIRCE Study Group. Prevalence of chronic renal disease in Spain: results of the EPIRCE study. Nefrologia. 2010;30(1):78-86.
7. Manjunath G, Sarnak MJ, Levey AS. Prediction equations to estimate glomerular filtration rate: an update. Curr Opin Nephrol Hypertens. 2001;10(6):785-792.
8. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D; Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999;130(6):461-470.
9. Levey AS, Stevens LA, Schmid CH, et al; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604-612.
10. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39 (2)(Suppl 1):S1S266.
11. Levey AS, de Jong PE, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 2011;80(1):17-28.
12. Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CL, Lozano R, Inoue M. Age standardization of rates: a new WHO standard. GPE Discussion Paper Series: No. 31. EIP/GPE/EBD. Geneva: World Health Organization.
13. Buitrago F, Calvo JI, Gómez-Jiménez C, Cañón L, Robles NR, Angulo E. Comparison and agreement of the Cockcroft Gault and MDRD equations to estimate glomerular filtration rate in diagnosis of occult chronic kidney disease [article in Spanish]. Nefrologia. 2008;28(3):301-310.
14. Gómez Navarro R. Prevalencia de la enfermedad renal crónica determinada mediante la aplicación de ecuaciones predictivas en personas hipertensas atendidas en Atención Primaria. Rev Esp Salud Publica. 2009;83(3):463-469.
15. Lou Arnal LM, Campos Gutiérrez B, Cuberes Izquierdo M, et al; Grupo de Investigación ERC Aragón. [Prevalence of chronic kidney disease in patients with type 2 diabetes mellitus treated in primary care] [article in Spanish]. Nefrologia. 2010;30(5):552-556.
16. De Francisco ALM, De la Cruz JJ, Cases A, et al. Prevalencia de insuficiencia renal en Centros de Atención Primaria en España: estudio EROCAP. Nefrologia. 2007;27:300-312.
17. Cases Amenós A, González-Juanatey JR, Conthe Gutiérrez P, Matalí Gilarranz A, Garrido Costa C. Prevalence of chronic kidney disease in patients with or at a high risk of cardiovascular disease. Rev Esp Cardiol. 2010;63(2):225-228.
18. Hallan SI, Coresh J, Astor BC, et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol. 2006;17(8):2275-2284.
19. De Zeeuw D, Hillege HL, de Jong PE. The kidney, a cardiovascular risk marker and a new target for therapy. Kidney Int Suppl. 2005;(98):S25-S29.
20. Gambaro G, Yabarek T, Graziani MS, et al; INCIPE Study Group. Prevalence of CKD in northeastern Italy: results of the INCIPE study and comparison with NHANES. Clin J Am Soc Nephrol. 2010;5(11):1946-1953.
21. Stevens LA, Coresh J, Feldman HI, et al. Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol. 2007;18(10):2749-2757.
22. Bakris GL, Williams M, Dworkin L, et al; National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Preserving renal function in adults with hypertension and diabetes: a consensus approach. Am J Kidney Dis. 2000;36(3):646-661.
23. Morales E, Valero MA, León M, Hernández E, Praga M. Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. Am J Kidney Dis. 2003;41(2):319-327.
24. Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K. Pyorala K; For the DECODE Study Group. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med. 2004;164:1066-1076.
25. Jafar TH, Schmid CH, Landa M, et al; ACE Inhibition in Progressive Renal Disease Study Group. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease: a meta-analysis of patient-level data. Ann Intern Med. 2001;135(2):73-87.
26. Weiss JW, Johnson ES, Petrik A, Smith DH, Yang X, Thorp ML. Systolic blood pressure and mortality among older community-dwelling adults with CKD. Am J Kidney Dis. 2010;56(6):1062-1071.
27. Gabriel R, Alonso M, Segura A, et al; ERICE Cooperative Group. Prevalence, geographic distribution and geographic variability of major cardiovascular risk factors in Spain. Pooled analysis of data from population-based epidemiological studies: the ERICE Study. Rev Esp Cardiol. 2008;61(10):1030-1040.
28. Buitrago F, Calvo-Hueros JI, Gómez-Jiménez C, Cañón-Barroso L. Suárez-González, Robles NR. Hidden chronic renal insufficiency and cardiovascular events inpatients with hypertension in a primary care center. Ren Fail. 2010;32:757-765.
29. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project: registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation. 1994;90(1):583-612.
30. Yasuno S, Ueshima K, Oba K, et al. Clinical significance of left ventricular hypertrophy and changes in left ventricular mass in high-risk hypertensive patients: a subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan trial. J Hypertens. 2009;27(8):1705-1712.